Dear colleagues and friends,
We are honored to welcome you to this meeting of the international human genetics community. We look forward to bringing together geneticists, medical geneticists, genomics researchers, metabolomics scientists, evolutionary biologists, bioinformaticians, and so many other professionals who share a common passion: understanding the nature of the human genome and transforming that knowledge into improved health for people.
What will take place from March 1st to 5th, 2027, in Guadalajara will not simply be another congress. It will be a meeting of minds that are redefining what modern medicine means. When we look back, even just a decade ago, we dreamed of the possibility of sequencing an entire genome in hours. Today, that is routine. Not long ago, gene therapy was science fiction. Today, we save lives. The speed of change is dizzying, and you are the architects of that transformation.
We live in an era where genetics is no longer just an academic discipline confined to the laboratory. It has become central to how we think about health, disease, and the future of humanity. Patients arriving at genomic medicine clinics expect answers that were impossible not long ago. Families burdened with diagnoses of rare diseases look to us for hope. And we must rise to the occasion.
Perhaps one of the most exciting conversations we must have is about how to live longer and better. It's not just about longevity, but about healthy longevity. In our laboratories and in our genomic data lie the clues to how we can age with dignity and vitality. At the same time, we face challenges that seem almost insurmountable: cancer remains the leading cause of death in our populations, but here's the extraordinary thing—each year we gain a better understanding of how to attack it at the molecular level, how to tailor our therapies to the unique genomic profiles of each tumor.
Diseases that defined past generations now have a molecular face. Take diabetes, heart disease, obesity, and neuropsychiatry. For years we searched for a single responsible gene. Then we realized that reality is far more beautiful and complex: intricate genetic architectures where hundreds or thousands of variants work together, interacting with the environment, our lifestyles, and our history. This kind of understanding—this integration of the biological with the environmental and the social—is what distinguishes us as modern scientists.
And let's not forget those patients who live in the shadows: rare diseases, orphan diseases. Many of you have experienced the indescribable joy of finally giving a name to an undiagnosed illness. A name. That alone, sometimes, is a gift for a family that has endured years of diagnostic odyssey. Now imagine if we combine that with targeted therapies, predictive genomics, and personalized preventive medicine. That is our future.
Today we have technologies in our hands that seem straight out of science fiction. We sequence not only DNA, but also RNA, proteins, and epigenomes. We look inside individual cells. We map gene regulatory networks. We use artificial intelligence to discover patterns the human eye could never see. But here's the important point: technology is the pencil, not the poet. The question we must constantly ask ourselves is: what is the purpose of all this? Who are we serving?
Bioinformatics and biology systems allow us to see the forest, not just the individual trees. We can model entire signaling pathways, understand how proteins communicate with each other, how biological systems behave as complex ecosystems. And this systemic view is what allows us to think about truly preventive medicine, not in the sense of guessing, but in the sense of predicting, understanding risks, and acting before disease manifests.
The last few years have also brought us the promise of integrated omics sciences. Genomics, transcriptomics, proteomics, metabolomics—all communicating with each other. It's not enough to know DNA if we don't know how it's expressed, if we don't understand the resulting proteins, if we don't see the metabolism those proteins generate. Integration isn't a luxury—it's a necessity.
So, in these five days, we won't just be presenting research. We'll be meeting. We'll be asking uncomfortable questions. We'll be learning about topics that may be outside our usual areas of expertise. We'll be building collaborations that may end up being the most important projects of our careers. Some of the best ideas emerge in the cafes and hallways between sessions, when a colleague from Europe meets one from Latin America, when a clinician has a deep conversation with a computational biologist.
We are living in extraordinary times. The mysteries of the human genome, which fascinated Watson, Crick, and Franklin more than seven decades ago, are now ours to unravel every day. We have the responsibility, but also the privilege, to use that knowledge wisely, ethically, and with deep consideration for the humanity we serve.
We invite you to share your best selves during these days. Ask questions. Challenge the status quo. Imagine new possibilities. Because human genetics is not just about molecules and sequences—it is about the people, the families, the communities who have better lives because of what we discover.
Welcome to Guadalajara. Welcome to this community that is rewriting the future of medicine.
With admiration and hope,
Organizing Committee
International Congress of Human Genetics 2027